(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM
Identifieur interne : 004F55 ( Main/Exploration ); précédent : 004F54; suivant : 004F56(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM
Auteurs : A. Jon Stoessl [Canada] ; E. Mak [Canada] ; Donaldb. Calne [Canada]Source :
- The Lancet [ 0140-6736 ] ; 1985.
Abstract
PHNO is a naphthoxazine compound with selective D2 agonist properties and a molecular structure unrelated to the morphine and ergot derivatives that have been used to treat Parkinson's disease. A double-blind, dose-ranging study on 8 patients showed that it is effective in the treatment of parkinsonism; its duration of effect of up to 6 h could make it useful for patients who experience wearing-off reactions with levodopa.
Url:
DOI: 10.1016/S0140-6736(85)92627-3
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000738
- to stream Istex, to step Curation: 000738
- to stream Istex, to step Checkpoint: 002527
- to stream Main, to step Merge: 005966
- to stream Main, to step Curation: 004F55
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></author><author><name sortKey="Mak, E" sort="Mak, E" uniqKey="Mak E" first="E." last="Mak">E. Mak</name></author><author><name sortKey="Calne, Donaldb" sort="Calne, Donaldb" uniqKey="Calne D" first="Donaldb." last="Calne">Donaldb. Calne</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3F63D38FCCAE9F923B30538459CCC8C55B38697D</idno><date when="1985" year="1985">1985</date><idno type="doi">10.1016/S0140-6736(85)92627-3</idno><idno type="url">https://api-v5.istex.fr/document/3F63D38FCCAE9F923B30538459CCC8C55B38697D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000738</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000738</idno><idno type="wicri:Area/Istex/Curation">000738</idno><idno type="wicri:Area/Istex/Checkpoint">002527</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002527</idno><idno type="wicri:doubleKey">0140-6736:1985:Stoessl A:propyl:hydroxynaphthoxazine:phno</idno><idno type="wicri:Area/Main/Merge">005966</idno><idno type="wicri:Area/Main/Curation">004F55</idno><idno type="wicri:Area/Main/Exploration">004F55</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">(+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, Department of Medicine, University of British Columbia Health Sciences Centre Hospital, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 1W5</wicri:regionArea><wicri:noRegion>British Columbia V6T 1W5</wicri:noRegion></affiliation></author><author><name sortKey="Mak, E" sort="Mak, E" uniqKey="Mak E" first="E." last="Mak">E. Mak</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, Department of Medicine, University of British Columbia Health Sciences Centre Hospital, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 1W5</wicri:regionArea><wicri:noRegion>British Columbia V6T 1W5</wicri:noRegion></affiliation></author><author><name sortKey="Calne, Donaldb" sort="Calne, Donaldb" uniqKey="Calne D" first="Donaldb." last="Calne">Donaldb. Calne</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, Department of Medicine, University of British Columbia Health Sciences Centre Hospital, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 1W5</wicri:regionArea><wicri:noRegion>British Columbia V6T 1W5</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">The Lancet</title><title level="j" type="abbrev">LANCET</title><idno type="ISSN">0140-6736</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1985">1985</date><biblScope unit="volume">326</biblScope><biblScope unit="issue">8468</biblScope><biblScope unit="page" from="1330">1330</biblScope><biblScope unit="page" to="1331">1331</biblScope></imprint><idno type="ISSN">0140-6736</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0140-6736</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">PHNO is a naphthoxazine compound with selective D2 agonist properties and a molecular structure unrelated to the morphine and ergot derivatives that have been used to treat Parkinson's disease. A double-blind, dose-ranging study on 8 patients showed that it is effective in the treatment of parkinsonism; its duration of effect of up to 6 h could make it useful for patients who experience wearing-off reactions with levodopa.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></noRegion><name sortKey="Calne, Donaldb" sort="Calne, Donaldb" uniqKey="Calne D" first="Donaldb." last="Calne">Donaldb. Calne</name><name sortKey="Mak, E" sort="Mak, E" uniqKey="Mak E" first="E." last="Mak">E. Mak</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F55 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004F55 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:3F63D38FCCAE9F923B30538459CCC8C55B38697D
|texte= (+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISM
}}
| This area was generated with Dilib version V0.6.29. |  |